Aktogen Competitors and Similar CompaniesClear all
Aktogen's competitors and similar companies include Arrowhead Pharmaceuticals and Wave Life Sciences.
 Aktogen Aktogen is a company that offers behaviour and genetic services for fruit fly, Drosophila melanogaster laboratories as well as pharmaceutical companies. |  Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development. |  Wave Life Sciences Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients. | |
Founding Date | Founding Date 2003 | Founding Date 2001 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Ramsey, GB HQ | Locations Pasadena, US HQ Madison, US San Diego, US | Locations Cambridge, US HQ Dublin 1, IE Kagoshima, JP Singapore, SG Birmingham, GB Lexington, US |
Employees | Employees 2 | Employees 13416% increase | Employees 23522% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.5 b | Valuation ($) 2.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $829.4m (FY, 2025) | Revenue (est.) $42.7m (FY, 2025) |
Net income | Net income N/A | Net income $30.1m (FY, 2025) | Net income ($204.4m) (FY, 2025) |
Operating ⚠ | |||
Patents Issued | Patents Issued N/A | Patents Issued 359 (FY, 2016) | Patents Issued 27 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 147.1m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Arrowhead Pharmaceuticals
HQ
Pasadena, US
Employees
134↑ 16% increase
Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development.
View companyWave Life Sciences
HQ
Cambridge, US
Employees
235↓ 22% decrease
Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.
View company